Correlation Between 4D Molecular and Aytu BioScience
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Aytu BioScience, you can compare the effects of market volatilities on 4D Molecular and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Aytu BioScience.
Diversification Opportunities for 4D Molecular and Aytu BioScience
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between FDMT and Aytu is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of 4D Molecular i.e., 4D Molecular and Aytu BioScience go up and down completely randomly.
Pair Corralation between 4D Molecular and Aytu BioScience
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 0.78 times more return on investment than Aytu BioScience. However, 4D Molecular Therapeutics is 1.29 times less risky than Aytu BioScience. It trades about -0.01 of its potential returns per unit of risk. Aytu BioScience is currently generating about -0.16 per unit of risk. If you would invest 801.00 in 4D Molecular Therapeutics on September 1, 2024 and sell it today you would lose (17.00) from holding 4D Molecular Therapeutics or give up 2.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Aytu BioScience
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Aytu BioScience |
4D Molecular and Aytu BioScience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Aytu BioScience
The main advantage of trading using opposite 4D Molecular and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.| 4D Molecular vs. Tff Pharmaceuticals | 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. Inhibrx | 4D Molecular vs. Enliven Therapeutics |
| Aytu BioScience vs. Aquestive Therapeutics | Aytu BioScience vs. Evoke Pharma | Aytu BioScience vs. Shionogi Co Ltd | Aytu BioScience vs. Sunshine Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |